D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 65 Citations 17,168 296 World Ranking 3970 National Ranking 2005

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Cancer

Kit S. Lam focuses on Biochemistry, Combinatorial chemistry, Peptide, Molecular biology and Peptide library. His Biochemistry research incorporates elements of Antibody and Primary biliary cirrhosis. His Combinatorial chemistry study combines topics in areas such as Phase, Polymer, Molecule, Solid-phase synthesis and Drug discovery.

Kit S. Lam combines subjects such as Sequence, Peptide sequence, Streptavidin, Chemical synthesis and Kinase with his study of Peptide. His Chemical synthesis research focuses on Bacteriophage and how it connects with Receptor. The study incorporates disciplines such as Cell, Cell surface receptor, Cancer cell, Peptidomimetic and Combinatorial Chemistry Techniques in addition to Peptide library.

His most cited work include:

  • A new type of synthetic peptide library for identifying ligand-binding activity (1864 citations)
  • The “One-Bead-One-Compound” Combinatorial Library Method (591 citations)
  • The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles (578 citations)

What are the main themes of his work throughout his whole career to date?

Kit S. Lam mainly focuses on Combinatorial chemistry, Peptide, Cancer research, Biochemistry and Cancer. His research investigates the connection between Combinatorial chemistry and topics such as Solid-phase synthesis that intersect with problems in Organic chemistry. The concepts of his Peptide study are interwoven with issues in Amino acid, Peptide sequence, Computational biology and Integrin.

His Cancer research research is multidisciplinary, relying on both Breast cancer, Metastasis and Immunology. His work is dedicated to discovering how Biochemistry, Molecular biology are connected with Antibody and other disciplines. Kit S. Lam is interested in Cancer cell, which is a field of Cancer.

He most often published in these fields:

  • Combinatorial chemistry (24.25%)
  • Peptide (20.76%)
  • Cancer research (17.77%)

What were the highlights of his more recent work (between 2016-2021)?

  • Cancer research (17.77%)
  • Cell biology (5.98%)
  • Cancer (10.63%)

In recent papers he was focusing on the following fields of study:

Kit S. Lam mainly investigates Cancer research, Cell biology, Cancer, Drug delivery and Peptide. Kit S. Lam has included themes like Cancer cell, Breast cancer, Lung cancer and Cell growth in his Cancer research study. His Cell biology study integrates concerns from other disciplines, such as Integrin and Integrin binding.

His Integrin study is associated with Biochemistry. His Drug delivery study also includes fields such as

  • Nanoparticle and related Micelle, Biophysics and Photothermal therapy,
  • Biomedical engineering together with Magnetic resonance imaging and Nanoprobe,
  • Tumor microenvironment, which have a strong connection to Preclinical imaging. Kit S. Lam focuses mostly in the field of Peptide, narrowing it down to matters related to Tumor cells and, in some cases, Cancer immunotherapy.

Between 2016 and 2021, his most popular works were:

  • Combinatorial chemistry in drug discovery. (85 citations)
  • Tumor-targeting peptides from combinatorial libraries ☆ (72 citations)
  • Multispectral Optical Tweezers for Biochemical Fingerprinting of CD9-Positive Exosome Subpopulations. (40 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Cancer

His primary areas of investigation include Cancer research, Cell biology, Nanoparticle, Cancer and Drug delivery. His work carried out in the field of Cancer research brings together such families of science as Breast cancer, Immune system, Peptide and Cancer immunotherapy. Kit S. Lam performs integrative study on Peptide and Scalable design in his works.

His Cell biology research is multidisciplinary, relying on both Receptor, Integrin, Integrin binding and In vitro. His studies deal with areas such as Pharmacology and Tumor cells as well as Cancer. Kit S. Lam has included themes like Photothermal therapy, Micelle, Doxorubicin, Chromatography and Biomedical engineering in his Drug delivery study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A new type of synthetic peptide library for identifying ligand-binding activity

Kit S. Lam;Sydney E. Salmon;Evan M. Hersh;Victor J. Hruby.
Nature (1992)

2465 Citations

The “One-Bead-One-Compound” Combinatorial Library Method

Kit S. Lam;and Michal Lebl;Viktor Krchňák.
Chemical Reviews (1997)

917 Citations

The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles

Kai Xiao;Yuanpei Li;Juntao T Luo;Joyce S Lee.
Biomaterials (2011)

776 Citations

Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof

Kit Sang Lam;Sydney E. Salmon;Victor J. Hruby;Evan M. Hersh.
(1991)

747 Citations

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Primo N. Lara;Roger Higdon;Nelson Lim;Karen Kwan.
Journal of Clinical Oncology (2001)

562 Citations

Peptide and small molecule microarray for high throughput cell adhesion and functional assays.

James R. Falsey;M. Renil;Steven Park;Shijun Li.
Bioconjugate Chemistry (2001)

452 Citations

Therapeutic cancer targeting peptides.

Olulanu H. Aina;Thomas C. Sroka;Man-Ling Chen;Kit S. Lam.
Biopolymers (2002)

404 Citations

Well‐Defined, Reversible Boronate Crosslinked Nanocarriers for Targeted Drug Delivery in Response to Acidic pH Values and cis‐Diols

Yuanpei Li;Wenwu Xiao;Kai Xiao;Lorenzo Berti.
Angewandte Chemie (2012)

355 Citations

A smart and versatile theranostic nanomedicine platform based on nanoporphyrin

Yuanpei Li;Tzu-yin Lin;Yan Luo;Yan Luo;Qiangqiang Liu;Qiangqiang Liu.
Nature Communications (2014)

333 Citations

Application of combinatorial library methods in cancer research and drug discovery.

K S Lam.
Anti-cancer Drug Design (1997)

326 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kit S. Lam

M. Eric Gershwin

M. Eric Gershwin

University of California, Davis

Publications: 144

Carlo Selmi

Carlo Selmi

Humanitas University

Publications: 81

Patrick S.C. Leung

Patrick S.C. Leung

University of California, Davis

Publications: 64

Thomas Kodadek

Thomas Kodadek

Scripps Research Institute

Publications: 52

Carlito B. Lebrilla

Carlito B. Lebrilla

University of California, Davis

Publications: 46

Ross L. Coppel

Ross L. Coppel

Monash University

Publications: 43

Aftab A. Ansari

Aftab A. Ansari

Emory University

Publications: 42

Pietro Invernizzi

Pietro Invernizzi

University of Milano-Bicocca

Publications: 39

Richard A. Houghten

Richard A. Houghten

Torrey Pines Institute For Molecular Studies

Publications: 37

Bin Ding

Bin Ding

Donghua University

Publications: 36

Koichi Tsuneyama

Koichi Tsuneyama

University of Tokushima

Publications: 36

Dehua Pei

Dehua Pei

The Ohio State University

Publications: 35

Jianyong Yu

Jianyong Yu

Donghua University

Publications: 33

Xuesi Chen

Xuesi Chen

Chinese Academy of Sciences

Publications: 32

Zhiyuan Zhong

Zhiyuan Zhong

Soochow University

Publications: 28

Morten Meldal

Morten Meldal

University of Copenhagen

Publications: 28

Something went wrong. Please try again later.